5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.78▼ | 3.76▲ | 3.73▲ | 3.75▲ | 3.72▲ |
MA10 | 3.78▼ | 3.73▲ | 3.71▲ | 3.76▼ | 4.00▼ |
MA20 | 3.78▼ | 3.72▲ | 3.72▲ | 3.71▲ | 4.92▼ |
MA50 | 3.74▲ | 3.73▲ | 3.76▲ | 4.09▼ | 5.41▼ |
MA100 | 3.72▲ | 3.77▼ | 3.73▲ | 5.07▼ | 6.37▼ |
MA200 | 3.72▲ | 3.71▲ | 3.80▼ | 5.38▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | 0.012▲ | 0.008▲ | 0.037▲ | -0.117▼ |
RSI | 47.013▼ | 55.932▲ | 53.421▲ | 45.320▼ | 33.547▼ |
STOCH | 28.571 | 67.106 | 58.000 | 47.196 | 18.244▼ |
WILL %R | -100.000▼ | -37.838 | -35.000 | -49.565 | -82.117▼ |
CCI | -175.264▼ | 92.179 | 147.687▲ | 47.914 | -76.543 |
Tuesday, April 29, 2025 02:11 PM
About Cytek Biosciences, Inc. Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution ...
|
Tuesday, April 29, 2025 02:00 PM
Company to Conduct Demonstrations, Educational Workshops and Tutorials at Key Industry EventsFREMONT, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Continuing its commitment to advancing cell analysis, ...
|
Monday, April 28, 2025 05:15 AM
Cytek Biosciences' innovative FSP tech, strong financials, and growing cloud base position it for future growth. See what to expect from CTKB's Q1 results.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 3.83 | 3.83 | 3.755 | 3.76 | 73,296 |
01/05/25 | 3.74 | 3.87 | 3.615 | 3.70 | 418,899 |
30/04/25 | 3.68 | 3.75 | 3.61 | 3.71 | 455,174 |
29/04/25 | 3.84 | 3.84 | 3.70 | 3.74 | 372,142 |
28/04/25 | 3.79 | 3.87 | 3.76 | 3.86 | 612,649 |
25/04/25 | 3.77 | 3.86 | 3.725 | 3.77 | 590,832 |
24/04/25 | 3.78 | 3.82 | 3.73 | 3.82 | 740,703 |
23/04/25 | 3.90 | 4.045 | 3.76 | 3.77 | 600,457 |
22/04/25 | 3.76 | 3.83 | 3.715 | 3.785 | 505,353 |
21/04/25 | 3.58 | 3.72 | 3.47 | 3.70 | 1,000,982 |
|
|
||||
|
|
||||
|
|